Skip to main content

Zeripatamig

Chemical FDA Substance Registry (openFDA)
Chemical Identification
CAS Number2607644-43-7
Known Aliases (7)
Common Name
ANTI-CD47/CD19 BISPECIFIC MONOCLONAL ANTIBODY TG-1801 Immunoglobulin G1 [de-446-lysine], bispecific, anti-(human CD19 antigen) (human monoclonal TG-1801 γ1-chain) disulfide with human monoclonal TG-1801 λ-chain, bis(disulfide) with immunoglobulin G1 anti-(human CD47 antigen) (human monoclonal TG-1801 γ1-chain) disulfide with human monoclonal TG-1801 κ-chain immunoglobulin G1-kappa/lambda, anti-[Homo sapiens CD47 (integrin-associated protein, IAP, MER6, OA3) and anti-[Homo sapiens CD19 (B lymphocyte surface antigen B4, Leu-12)], Homo sapiens monoclonal antibody, bispecific TG-1801 TG1801 TG 1801 [WHO-DD] zeripatamig [INN]
Data Sources (1)
Source Source ID Name in Source Properties
FDA Substance Registry (openFDA) BK3WC9ZP7A Zeripatamig CAS: 2607644-43-7
INN: 12219
SMS_ID: 300000033168
FDA UNII: BK3WC9ZP7A
NCI_THESAURUS: C166137
Record Info
IDkE2pokqjDhkuF8NgqWdyN5
CreatedApril 10, 2026, 8:07 p.m.
ModifiedApril 11, 2026, 12:25 a.m.
Data SourceFDA Substance Registry (openFDA)